LOGSX Holdings — Live Oak Health Sciences Fund
All 28 reported holdings of Live Oak Health Sciences Fund (LOGSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| United Therapeutics Corp. | 6.40% | $3.17M |
| Cardinal Health, Inc. | 5.57% | $2.76M |
| Jazz Pharmaceuticals PLC | 5.25% | $2.60M |
| Novartis AG | 5.01% | $2.48M |
| Cencora, Inc. | 5.00% | $2.47M |
| Amgen, Inc. | 4.95% | $2.45M |
| Mount Vernon Liquid Assets Portfolio, LLC | 4.90% | $2.43M |
| Mckesson Corp. | 4.89% | $2.42M |
| Exelixis, Inc. | 4.71% | $2.33M |
| Regeneron Pharmaceuticals, Inc. | 4.66% | $2.31M |
| Lantheus Holdings, Inc. | 4.50% | $2.23M |
| Johnson & Johnson | 3.83% | $1.90M |
| Bristol-Myers Squibb Company | 3.67% | $1.82M |
| Cigna Group (the) | 3.55% | $1.76M |
| Gilead Sciences, Inc. | 3.54% | $1.75M |
| National Healthcare Corp. | 3.36% | $1.67M |
| Vertex Pharmaceuticals, Inc. | 3.31% | $1.64M |
| Intuitive Surgical, Inc. | 3.25% | $1.61M |
| Medpace Holdings, Inc. | 3.04% | $1.50M |
| Merck & Company, Inc. | 3.01% | $1.49M |
| Incyte Corp. | 2.98% | $1.48M |
| Stryker Corp. | 2.16% | $1.07M |
| Labcorp Holdings, Inc. | 2.15% | $1.07M |
| Medtronic PLC | 2.02% | $1.00M |
| Eli Lilly & Company | 1.83% | $906.56K |
| Novo Nordisk A/s | 1.70% | $840.47K |
| Elevance Health, Inc. | 1.23% | $610.18K |
| Ensign Group, Inc. (the) | 1.18% | $586.39K |
LOGSX overview: performance, fees, allocation and SEC filings